Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome

Virology

Volumn 412, Issue 2, 2011, Pages 306-314

  Barlan, A U ^a   Danthi, P ^b   Wiethoff, C M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Cathepsin B; Fiber; Inflammasome; Lysosomes; Nonenveloped virus

Indexed keywords

CATHEPSIN B; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TOLL LIKE RECEPTOR 9;

ADENOVIRUS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENDOSOME; HUMAN; HUMAN CELL; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REOVIRUS; SIGNAL TRANSDUCTION; VIRUS ACTIVATION; VIRUS ENTRY; VIRUS ENVELOPE;

ADENOVIRIDAE; CARRIER PROTEINS; CATHEPSIN B; CELL LINE; HUMANS; INFLAMMASOMES; LYSOSOMES; REOVIRIDAE; TOLL-LIKE RECEPTOR 9; VIRUS ACTIVATION; VIRUS INTERNALIZATION;

ADENOVIRIDAE; ORTHOREOVIRUS;

EID: 79952621850     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.019     Document Type: Article

References (72)

1. Agosto M.A., Ivanovic T., Nibert M.L. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl Acad. Sci. USA 2006, 103(44):16496-16501.
2. Appledorn D.M., Patial S., McBride A., Godbehere S., Van Rooijen N., Parameswaran N., Amalfitano A. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 2008, 181(3):2134-2144.
3. Barlan A.U., Griffin T.M., McGuire K.A., Wiethoff C.M. Adenovirus membrane penetration activates the NLRP3 inflammasome. J. Virol. 2011, 85(1):146-155.
4. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., Macdonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-{kappa}B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183(2):787-791.
5. Benko M., Harrach B. Molecular evolution of adenoviruses. Curr. Top. Microbiol. Immunol. 2003, 272:3-35.
6. Berclaz P.Y., Shibata Y., Whitsett J.A., Trapnell B.C. GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma-mediated molecular connection between innate and adaptive immunity in the lung. Blood 2002, 100(12):4193-4200.
7. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81(1):1-5.
8. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 2006, 177(10):7094-7102.
9. Brabec M., Blaas D., Fuchs R. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments. Biochem. Biophys. Res. Commun. 2006, 348(2):741-749.
10. Cerullo V., Seiler M.P., Mane V., Brunetti-Pierri N., Clarke C., Bertin T.K., Rodgers J.R., Lee B. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 2007, 15(2):378-385.
11. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 2003, 77(8):4588-4596.
12. Cotten M., Weber J.M. The adenovirus protease is required for virus entry into host cells. Virology 1995, 213(2):494-502.
13. Danthi P., Kobayashi T., Holm G.H., Hansberger M.W., Abel T.W., Dermody T.S. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J. Virol. 2008, 82(1):161-172.
14. Danthi P., Guglielmi K.M., Kirchner E., Mainou B., Stehle T., Dermody T.S. From touchdown to transcription: the reovirus cell entry pathway. Curr. Top. Microbiol. Immunol. 2010, 343:91-119.
15. Di Paolo N.C., Miao E.A., Iwakura Y., Murali-Krishna K., Aderem A., Flavell R.A., Papayannopoulou T., Shayakhmetov D.M. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 2009, 31(1):110-121.
16. Duncan J.A., Gao X., Huang M.T., O'Connor B.P., Thomas C.E., Willingham S.B., Bergstralh D.T., Jarvis G.A., Sparling P.F., Ting J.P. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 2009, 182(10):6460-6469.
17. Ebert D.H., Deussing J., Peters C., Dermody T.S. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 2002, 277(27):24609-24617.
18. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453(7198):1122-1126.
19. Fejer G., Drechsel L., Liese J., Schleicher U., Ruzsics Z., Imelli N., Greber U.F., Keck S., Hildenbrand B., Krug A., Bogdan C., Freudenberg M.A. Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog. 2008, 4(11):e1000208.
20. Furlong D.B., Nibert M.L., Fields B.N. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 1988, 62(1):246-256.
21. Ghavami S., Asoodeh A., Klonisch T., Halayko A.J., Kadkhoda K., Kroczak T.J., Gibson S.B., Booy E.P., Naderi-Manesh H., Los M. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J. Cell. Mol. Med. 2008, 12(3):1005-1022.
22. Ginsberg H.S., Prince G.A. The molecular basis of adenovirus pathogenesis. Infect. Agents Dis. 1994, 3(1):1-8.
23. Granberg F., Svensson C., Pettersson U., Zhao H. Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology 2005, 343(2):236-245.
24. Greber U.F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993, 75(3):477-486.
25. Greber U.F., Webster P., Weber J., Helenius A. The role of the adenovirus protease on virus entry into cells. EMBO J. 1996, 15(8):1766-1777.
26. Hansberger M.W., Campbell J.A., Danthi P., Arrate P., Pennington K.N., Marcu K.B., Ballard D.W., Dermody T.S. IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus. J. Virol. 2007, 81(3):1360-1371.
27. Holm G.H., Zurney J., Tumilasci V., Leveille S., Danthi P., Hiscott J., Sherry B., Dermody T.S. Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J. Biol. Chem. 2007, 282(30):21953-21961.
28. Hornung V., Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010, 40(3):620-623.
29. Howitt J., Anderson C.W., Freimuth P. Adenovirus interaction with its cellular receptor CAR. Curr. Top. Microbiol. Immunol. 2003, 272:331-364.
30. Hsu C., Boysen M., Gritton L.D., Frosst P.D., Nemerow G.R., Von Seggern D.J. In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity. Virology 2005, 332(1):1-7.
31. Iacobelli-Martinez M., Nemerow G.R. Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J. Virol. 2007, 81(3):1305-1312.
32. Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206(1):79-87.
33. Ivanovic T., Agosto M.A., Zhang L., Chandran K., Harrison S.C., Nibert M.L. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J. 2008, 27(8):1289-1298.
34. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 2008, 1143:1-20.
35. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl Acad. Sci. USA 2004, 101(5):1315-1320.
36. Leen A.M., Rooney C.M. Adenovirus as an emerging pathogen in immunocompromised patients. Br. J. Haematol. 2005, 128(2):135-144.
37. Li H., Willingham S.B., Ting J.P., Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 2008, 181(1):17-21.
38. Maier O., Galan D.L., Wodrich H., Wiethoff C.M. An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 2010, 402(1):11-19.
39. Marsh M., Pelchen-Matthews A. Endocytosis in viral replication. Traffic 2000, 1(7):525-532.
40. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
41. Miyazawa N., Leopold P.L., Hackett N.R., Ferris B., Worgall S., Falck-Pedersen E., Crystal R.G. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 1999, 73(7):6056-6065.
42. Miyazawa N., Crystal R.G., Leopold P.L. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 2001, 75(3):1387-1400.
43. Muruve D.A. The innate immune response to adenovirus vectors. Hum. Gene Ther. 2004, 15(12):1157-1166.
44. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., Parks R.J., Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452(7183):103-107.
45. Nemerow G.R. Cell receptors involved in adenovirus entry. Virology 2000, 274(1):1-4.
46. Nociari M., Ocheretina O., Schoggins J.W., Falck-Pedersen E. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 2007, 81(8):4145-4157.
47. Nociari M., Ocheretina O., Murphy M., Falck-Pedersen E. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J. Virol. 2009, 83(9):4081-4091.
48. Qian M., Cai D., Verhey K.J., Tsai B. A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Pathog. 2009, 5(6):e1000465.
49. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., Wilson J.M., Batshaw M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 2003, 80(1-2):148-158.
50. Sakurai F., Kawabata K., Mizuguchi H. Adenovirus vectors composed of subgroup B adenoviruses. Curr. Gene Ther. 2007, 7(4):229-238.
51. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327(5963):296-300.
52. Scibetta A.G., Copier J., Barrett A., Chaplin T., Taylor-Papadimitriou J. Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells. Intervirology 2005, 48(6):350-361.
53. Shayakhmetov D.M., Li Z.Y., Ternovoi V., Gaggar A., Gharwan H., Lieber A. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J. Virol. 2003, 77(6):3712-3723.
54. Shayakhmetov D.M., Li Z.Y., Ni S., Lieber A. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors. J. Immunol. 2005, 174(11):7310-7319.
55. Silvestry M., Lindert S., Smith J.G., Maier O., Wiethoff C.M., Nemerow G.R., Stewart P.L. Cryoelectron microscopy structure of the adenovirus type 2 temperature sensitive mutant 1 reveals insight into the cell entry defect. J. Virol. 2009, 83(15):7375-7383.
56. Smith J.G., Cassany A., Gerace L., Ralston R., Nemerow G.R. Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J. Virol. 2008, 82(13):6492-6500.
57. Suikkanen S., Antila M., Jaatinen A., Vihinen-Ranta M., Vuento M. Release of canine parvovirus from endocytic vesicles. Virology 2003, 316(2):267-280.
58. Tibbles L.A., Spurrell J.C., Bowen G.P., Liu Q., Lam M., Zaiss A.K., Robbins S.M., Hollenberg M.D., Wickham T.J., Muruve D.A. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 2002, 76(4):1559-1568.
59. Tsai B. Penetration of nonenveloped viruses into the cytoplasm. Annu. Rev. Cell Dev. Biol. 2007, 23:23-43.
60. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 2010, 10(3):210-215.
61. Tuve S., Wang H., Jacobs J.D., Yumul R.C., Smith D.F., Lieber A. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog. 2008, 4(10):e1000189.
62. Varghese R., Mikyas Y., Stewart P.L., Ralston R. Postentry neutralization of adenovirus type 5 by an antihexon antibody. J. Virol. 2004, 78(22):12320-12332.
63. Wang H., Ward M.F., Fan X.G., Sama A.E., Li W. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol. 2006, 19(1):3-9.
64. Weber J. Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J. Virol. 1976, 17(2):462-471.
65. Wiethoff C.M., Wodrich H., Gerace L., Nemerow G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 2005, 79(4):1992-2000.
66. Willingham S.B., Bergstralh D.T., O'Connor W., Morrison A.C., Taxman D.J., Duncan J.A., Barnoy S., Venkatesan M.M., Flavell R.A., Deshmukh M., Hoffman H.M., Ting J.P. Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2007, 2(3):147-159.
67. Ye Z., Ting J.P. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 2008, 20(1):3-9.
68. Zaiss A.K., Vilaysane A., Cotter M.J., Clark S.A., Meijndert H.C., Colarusso P., Yates R.M., Petrilli V., Tschopp J., Muruve D.A. Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response. J. Immunol. 2009, 182(11):7058-7068.
69. Zhang L., Agosto M.A., Ivanovic T., King D.S., Nibert M.L., Harrison S.C. Requirements for the formation of membrane pores by the reovirus myristoylated micro1N peptide. J. Virol. 2009, 83(14):7004-7014.
70. Zhao H., Granberg F., Elfineh L., Pettersson U., Svensson C. Strategic attack on host cell gene expression during adenovirus infection. J. Virol. 2003, 77(20):11006-11015.
71. Zhu J., Huang X., Yang Y. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J. Virol. 2007, 81(7):3170-3180.
72. Zhu J., Huang X., Yang Y. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Invest. 2009, 119(8):2388-2398.